Inovexa is a Bulgarian product and analytical development laboratory specialised in generic dossier development of finished pharmaceutical forms for oral use. Operational since May 2020, Inovexa is the first independent private Bulgarian pharmaceutical company solely focusing on generic R&D as a core activity. Tsvetan Popov has 20 years of experience in generic multinational companies and is a managing director at Inovexa.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
